You just read:

Blueprint Medicines to Report Updated Data from the Phase 2 PIONEER Trial of Avapritinib in Indolent Systemic Mastocytosis on Monday, March 16, 2020

News provided by

Blueprint Medicines Corporation

Mar 09, 2020, 09:00 ET